Lrrk2 mutations in south america: a study of Chilean Parkinson's disease

被引:20
|
作者
Perez-Pastene, Carolina
Cobb, Stephanie A.
Diaz-Grez, Fernando
Hulihan, Mary A.
Miranda, Marcelo
Venegas, Pablo
Godoy, Osvaldo Trujillo
Kachergus, Jennifer M.
Ross, Owen A.
Layson, Luis
Farrer, Matthew J.
Segura-Aguilar, Juan
机构
[1] Univ Chile, Fac Med, ICBM, Programme Mol & Clin Pharmacol, Santiago 7, Chile
[2] Mayo Clin, Coll Med, Dept Neurosci, Jacksonville, FL 32224 USA
关键词
LRRK2; Parkinson's disease; mutation; Amerindian;
D O I
10.1016/j.neulet.2007.06.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Pathogenic substitutions in the leucine-rich repeat kinase 2 protein (Lrrk2), R1441G and G2019S, area prevalent cause of autosomal dominant and sporadic Parkinson's disease in the Northern Spanish population. In this study we examined the frequency of these two substitutions in 166 Parkinson's disease patients and 153 controls from Chile, a population with Spanish/European-Amerindian admixture. Lrrk2 R1441G was not observed, however Lrrk2 G2019S was detected in one familial and four sporadic Parkinson's disease patients. These findings suggest Lrrk2 G2019S may play an important role in Parkinson's disease on the South American Continent and further studies are now warranted. (c) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:193 / 197
页数:5
相关论文
共 50 条
  • [31] LRRK2 and Proteostasis in Parkinson's Disease
    Perez-Carrion, Maria Dolores
    Posadas, Inmaculada
    Solera, Javier
    Cena, Valentin
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (12)
  • [32] LRRK2 and idiopathic Parkinson's disease
    Rocha, Emily M.
    Keeney, Matthew T.
    Di Maio, Roberto
    De Miranda, Briana R.
    Greenamyre, J. Timothy
    TRENDS IN NEUROSCIENCES, 2022, 45 (03) : 224 - 236
  • [33] Increased Stroke Risk in Patients with Parkinson's Disease with LRRK2 Mutations
    Macias-Garcia, Daniel
    Perinan, Maria Teresa
    Munoz-Delgado, Laura
    Jesus, Silvia
    Jimenez-Jaraba, Maria Valle
    Buiza-Rueda, Dolores
    Bonilla-Toribio, Marta
    Adarmes-Gomez, Astrid
    Carrillo, Fatima
    Gomez-Garre, Pilar
    Mir, Pablo
    MOVEMENT DISORDERS, 2022, 37 (01) : 225 - 227
  • [34] Molecular biology changes associated with LRRK2 mutations in Parkinson's disease
    Lu, Yi Wei
    Tan, Eng-King
    JOURNAL OF NEUROSCIENCE RESEARCH, 2008, 86 (09) : 1895 - 1901
  • [35] LRRK2 and GBA Founder Mutations and their Interactions in Parkinson's disease (PD)
    Kmiecik, M.
    Riboldi, G.
    Schneider, R.
    Stagaman, K.
    Sonmez, T. Filshtein
    Guan, A.
    Wetzel, M.
    Fontanillas, P.
    Holmes, M.
    Aslibekyan, S.
    Norcliffe-Kaufmann, L.
    MOVEMENT DISORDERS, 2024, 39 : S761 - S761
  • [36] Targeting LRRK2 in Parkinson's disease
    Xiao, Bin
    Tan, Eng-King
    CELL REPORTS MEDICINE, 2022, 3 (10)
  • [37] Alpha-synuclein oligomers in Parkinson's disease with LRRK2 mutations
    Sekiya, H.
    Hashimoto, Y.
    Takata, M.
    Koga, S.
    Hasegawa, K.
    Kowa, H.
    Toda, T.
    Wszolek, Z.
    Dickson, D.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2023, 82 (06): : 514 - 514
  • [38] Identification of novel mutations in LRRK2 gene in patients with Parkinson's disease
    Jankovic, M.
    Kresojevic, N. D.
    Dobricic, V.
    Markovic, V.
    Petrovic, I.
    Novakovic, I.
    Kostic, V. S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 354 - 354
  • [39] Association Between Cancer and LRRK2 Mutations in Parkinson's Disease Patients
    Inzelberg, R.
    Hassin-Baer, S.
    Cohen, O. S.
    Aharon-Peretz, J.
    Schlesinger, I.
    Gershoni, R.
    Djaldetti, R.
    Schechtman, E.
    Friedman, E.
    MOVEMENT DISORDERS, 2010, 25 : S648 - S649
  • [40] LRRK2 mutations in patients with Parkinson's disease from Peru and Uruguay
    Mata, I. F.
    Cosentino, C.
    Torres, L.
    Malca, V.
    Maeti, P.
    Ortega, O.
    Raggio, V.
    Aljanati, R.
    Ramos, G.
    Avila, A.
    Dieguez, E.
    Zabetian, C. P.
    MOVEMENT DISORDERS, 2008, 23 (01) : S50 - S50